NCT02165969

Brief Summary

The purpose of this study is to compare a subject's sense of smell before and after endoscopic endonasal surgery to remove a skull base abnormality (i.e. tumor, inflammatory process, fracture, defect, etc.) and use the information collected to validate approaches to surgery that will minimize side effects to the sense of smell function. Data will be collected using a smell identification test along with two questionnaires. In addition, demographic, medical history, treatment, outcome, and follow-up information will be collected.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 23, 2014

Completed
9 days until next milestone

Study Start

First participant enrolled

June 1, 2014

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 18, 2014

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 25, 2017

Completed
8.5 years until next milestone

Results Posted

Study results publicly available

April 27, 2026

Completed
Last Updated

April 27, 2026

Status Verified

April 1, 2026

Enrollment Period

3.4 years

First QC Date

May 23, 2014

Results QC Date

March 7, 2018

Last Update Submit

April 23, 2026

Conditions

Keywords

tumorinflammatory processfracturedefect

Outcome Measures

Primary Outcomes (1)

  • Changes in UPSIT Score for the Two Groups Undergoing Endoscopic Endonasal Surgery With or Without Flap

    We measured olfactory function using the University of Pennsylvania Smell Identification Test (UPSIT) in the two groups, with and without nasoseptal flap. UPSIT scores are measured out of 40: 34-40 - normal smell for men; 35-40 - normal smell for women; 30-33 - mild microsmia; 26-29 - moderate microsmia; 19-25 - severe microsmia; 18 or less - anosmia. Exact thresholds vary by age and sex. Official tables are available to refine diagnosis. Minimum score is 0, and maximum score is 40.

    up to 12 months post surgery

Study Arms (2)

patients undergoing EEA requiring a nasoseptal flap

endoscopic endonasal surgery undergoing a nasoseptal flap for reconstruction monitored with UPSIT prior to surgery and at months 1, 3, 6, and 12 after surgery.

Procedure: endoscopic endonasal surgery with UPSIT

patients undergoing EEA NOT requiring a nasoseptal flap followed up with UPSIT

endoscopic endonasal surgery NOT undergoing a nasoseptal flap for reconstruction monitored with UPSIT prior to surgery and at months 1, 3, 6, and 12 after surgery.

Procedure: endoscopic endonasal surgery with UPSIT

Interventions

patients undergoing EEA NOT requiring a nasoseptal flap followed up with UPSITpatients undergoing EEA requiring a nasoseptal flap

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients presenting with skull base pathologies requiring endonasal surgery

You may qualify if:

  • Patients presenting with skull base pathologies requiring endonasal surgery at The Ohio State University Wexner Medical Center
  • years or older
  • Able to consent for self
  • Negative serum pregnancy test for women of childbearing potential

You may not qualify if:

  • Patient unable to return to clinic at specific follow-up times
  • Pregnant or nursing
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

NeoplasmsFractures, Bone

Condition Hierarchy (Ancestors)

Wounds and Injuries

Results Point of Contact

Title
Dr Ricardo Carrau
Organization
OSU Wexner Medical Center Department of Otolaryngology

Study Officials

  • Ricardo Carrau, MD

    Ohio State University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 23, 2014

First Posted

June 18, 2014

Study Start

June 1, 2014

Primary Completion

October 25, 2017

Study Completion

October 25, 2017

Last Updated

April 27, 2026

Results First Posted

April 27, 2026

Record last verified: 2026-04

Locations